Yesterday, the Non-Executive of Cronos Group (CRON), Jason Marc Adler, sold shares of CRON for $6.86M.
This is Adler’s first transaction since reporting a Buy transaction on ITHUF back in August 2019 In addition to Jason Marc Adler, 3 other CRON executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Cronos Group’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $11.36 million and quarterly net profit of $69.03 million. In comparison, last year the company earned revenue of $5.79 million and had a net profit of $604 million. The company has a one-year high of $9.00 and a one-year low of $4.00.
One of the top 25 analysts, according to TipRanks.com, recently recommended Sell CRON with a $6.50 price target. Based on 5 analyst ratings, the analyst consensus is Hold with an average price target of $5.97, reflecting a 15.9% upside.
The insider sentiment on Cronos Group has been negative according to 15 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
